Harbourvest Partners’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Harbourvest Partners’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-38,540	Closed	-$1.59M	–	39
2024 Q3	$1.59M	Hold	38,540	–	–	0.83%	14
2024 Q2	$1.86M	Hold	38,540	–	–	0.99%	13
2024 Q1	$1.85M	Hold	38,540	–	–	0.84%	15
2023 Q4	$2.5M	Hold	38,540	–	–	0.84%	15
2023 Q3	$2.52M	Hold	38,540	–	–	0.86%	17
2023 Q2	$2.24M	Hold	38,540	–	–	0.64%	24
2023 Q1	$2.38M	Hold	38,540	–	–	0.8%	18
2022 Q4	$2.45M	Hold	38,540	–	–	0.82%	18
2022 Q3	$2.8M	Hold	38,540	–	–	0.92%	19
2022 Q2	$2.62M	Hold	38,540	–	–	0.86%	22
2022 Q1	$3.49M	Hold	38,540	–	–	0.71%	21
2021 Q4	$3.52M	Hold	38,540	–	–	0.45%	24
2021 Q3	$3.13M	Sell	38,540 -50,058	-57%	-$4.21M	0.29%	24
2021 Q2	$8.26M	Sell	88,598 -58,877	-40%	-$5.71M	0.79%	14
2021 Q1	$15.8M	Buy	+147,475	New	+$15.3M	2.12%	7

Other funds holding NARI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Harbourvest Partners's NARI Position: Q4 2024 in Review

Harbourvest Partners sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2024, closing a stake of 38,540 shares — an estimated $1.59M sold.

Harbourvest Partners first reported a position in NARI in Q1 2021 and held it in 15 quarters. The position peaked at $15.8M in Q1 2021. 258 funds tracked by Wall St. Rank hold NARI as of Q4 2024.

Harbourvest Partners reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Harbourvest Partners sold 38,540 Inari Medical, Inc. Common Stock shares in Q4 2024, an estimated $1.59M.
Harbourvest Partners first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and held it in 15 quarters.
Harbourvest Partners's Inari Medical, Inc. Common Stock position peaked at $15.8M in Q1 2021.
258 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2024.

Based on Harbourvest Partners's 13F filing for Q4 2024, filed 14 Feb 2025.